Immune checkpoint blockers (ICBs) have revolutionized the treatment of non–small cell lung cancer (NSCLC). Currently, one-dose-fits-all maximalist regimens have been considered the standard of care, ...

Tom Fitzgerald discusses the history and impact of USAID around the world with George Ingram, a former USAID officials and ...

Tim Berners-Lee, a British scientist, invented the World Wide Web (WWW) in 1989, while working at CERN. The Web was originally conceived and developed to meet the demand for automated ...

How one of the biggest financial companies in Kazakhstan emerged and developed in the market Timur Turlov is the founder, CEO, and majority shareholder of the international diversified financial ...

The Greenburgh Black History Museum Initiative is officially live and will be exhibited at the Greenburgh Public Library, 300 Tarrytown Road, Elmsford, NY, from February 2nd through March 15th, 2025.

Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...

Shares of Regeneron Pharmaceuticals have plunged more than 30% over the past six months, but one Wall Street analyst believes ...

Elsewhere, cell therapy developer Turnstone Biologics announced a second round of layoffs and plans to explore “strategic alternatives.” ...

REGN reports better-than-expected Q4 results. However, lead drug Eylea sales decline in the United States due to competition.

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

Despite lackluster sales of Eylea’s high-dose formulation and Sanofi-partnered Dupixent, Regeneron beat Q4 forecasts overall ...

February 4, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and ...